Capricor Therapeutics
CAPR
#6000
Rank
ยฃ0.85 B
Marketcap
ยฃ14.79
Share price
-0.66%
Change (1 day)
206.75%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2026 (TTM): -ยฃ85.18 Million

According to Capricor Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ78.87 Million a decrease over its 2024 earnings that were of -ยฃ30.39 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ85.18 Million8%
2025 -ยฃ78.87 Million159.57%
2024 -ยฃ30.39 Million81.57%
2023 -ยฃ16.74 Million-23.2%
2022 -ยฃ21.79 Million44.93%
2021 -ยฃ15.04 Million46.61%
2020 -ยฃ10.26 Million78.71%
2019 -ยฃ5.74 Million-49.7%
2018 -ยฃ11.41 Million-724.78%
2017 ยฃ1.82 M-112.93%
2016 -ยฃ14.13 Million46.27%
2015 -ยฃ9.66 Million106.82%
2014 -ยฃ4.67 Million-48.41%
2013 -ยฃ9.05 Million977.23%
2012 -ยฃ0.84 Million-77.11%
2011 -ยฃ3.67 Million-22.35%
2010 -ยฃ4.73 Million-20.17%
2009 -ยฃ5.92 Million-41.17%
2008 -ยฃ10.07 Million41.05%
2007 -ยฃ7.14 Million1098.87%
2006 -ยฃ0.6 Million4101.55%
2005 -ยฃ0.02 Million-0.97%
2004 -ยฃ0.02 Million17.87%
2003 -ยฃ0.02 Million3.66%
2002 -ยฃ0.02 Million-30.11%
2001 -ยฃ0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.50 B-22,770.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ0.59 B-797.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-ยฃ0.63 Billion 623.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.24 Billion 169.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-ยฃ4.69 Million-94.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ11.21 Million-86.98%๐Ÿ‡บ๐Ÿ‡ธ USA